Literature DB >> 20374263

Anti-oxidant properties of high-density lipoprotein and atherosclerosis.

Eugene A Podrez1.   

Abstract

1. High-density lipoprotein (HDL) is one of the major carriers of cholesterol in the blood. It attracts particular attention because, in contrast with other lipoproteins, many physiological functions of HDL influence the cardiovascular system in favourable ways unless HDL is modified pathologically. 2. The best known function of HDL is the capacity to promote cellular cholesterol efflux from peripheral cells and deliver cholesterol to the liver for excretion, thereby playing a key role in reverse cholesterol transport. The functions of HDL that have recently attracted attention include anti-inflammatory and anti-oxidant activities. High anti-oxidant and anti-inflammatory activities of HDL are associated with protection from cardiovascular disease. 3. Atheroprotective activities, as well as a functional deficiency of HDL, ultimately depend on the protein and lipid composition of HDL. Conversely, these activities are compromised in many pathological states associated with inflammation. 4. The focus of the present review is on the anti-oxidant and anti-inflammatory functions of HDL and its individual components in relation to protection from atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20374263      PMCID: PMC3010184          DOI: 10.1111/j.1440-1681.2010.05380.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  89 in total

1.  Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice.

Authors:  F E Thorngate; L L Rudel; R L Walzem; D L Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

2.  Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry.

Authors:  Helen Karlsson; Per Leanderson; Christer Tagesson; Mats Lindahl
Journal:  Proteomics       Date:  2005-04       Impact factor: 3.984

3.  Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.

Authors:  Robert L Raffai; Samuel M Loeb; Karl H Weisgraber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-09       Impact factor: 8.311

4.  Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine.

Authors:  Mira Rosenblat; Jacob Vaya; Diana Shih; Michael Aviram
Journal:  Atherosclerosis       Date:  2004-12-29       Impact factor: 5.162

5.  Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis.

Authors:  D M Shih; Y R Xia; X P Wang; E Miller; L W Castellani; G Subbanagounder; H Cheroutre; K F Faull; J A Berliner; J L Witztum; A J Lusis
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

6.  Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides.

Authors:  N Chen; Y Liu; C D Greiner; J L Holtzman
Journal:  J Lab Clin Med       Date:  2000-07

Review 7.  Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.

Authors:  Philip W Connelly; Dragomir Draganov; Graham F Maguire
Journal:  Free Radic Biol Med       Date:  2005-01-15       Impact factor: 7.376

8.  Differential effects of clusterin/apolipoprotein J on cellular growth and survival.

Authors:  Ioannis P Trougakos; Magda Lourda; Georgia Agiostratidou; Dimitris Kletsas; Efstathios S Gonos
Journal:  Free Radic Biol Med       Date:  2005-02-15       Impact factor: 7.376

9.  Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis.

Authors:  D M Shih; L Gu; Y R Xia; M Navab; W F Li; S Hama; L W Castellani; C E Furlong; L G Costa; A M Fogelman; A J Lusis
Journal:  Nature       Date:  1998-07-16       Impact factor: 49.962

Review 10.  Oxidative modification of low-density lipoproteins in atherothrombosis.

Authors:  P Holvoet
Journal:  Acta Cardiol       Date:  1998       Impact factor: 1.718

View more
  36 in total

1.  HDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanisms.

Authors:  Benjamin Emert; Yehudit Hasin-Brumshtein; James R Springstead; Ladan Vakili; Judith A Berliner; Aldons J Lusis
Journal:  J Lipid Res       Date:  2014-05-23       Impact factor: 5.922

2.  ApoA-I/SR-BI modulates S1P/S1PR2-mediated inflammation through the PI3K/Akt signaling pathway in HUVECs.

Authors:  Kun Ren; Yan-Ju Lu; Zhong-Cheng Mo; Xing -Liu; Zhen-Li Tang; Yue Jiang; Xiao-Shan Peng; Li Li; Qing-Hai Zhang; Guang-Hui Yi
Journal:  J Physiol Biochem       Date:  2017-02-08       Impact factor: 4.158

3.  Analysis of covalent modifications of proteins by oxidized phospholipids using a novel method of peptide enrichment.

Authors:  Detao Gao; Belinda Willard; Eugene A Podrez
Journal:  Anal Chem       Date:  2014-01-02       Impact factor: 6.986

4.  High density lipoprotein and cardiovascular diseases.

Authors:  Theodosios D Filippatos; Moses S Elisaf
Journal:  World J Cardiol       Date:  2013-07-26

Review 5.  HDL and endothelial protection.

Authors:  A Tran-Dinh; D Diallo; S Delbosc; L Maria Varela-Perez; Q B Dang; B Lapergue; E Burillo; J B Michel; A Levoye; J L Martin-Ventura; O Meilhac
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

6.  Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.

Authors:  Detao Gao; Eugene A Podrez
Journal:  Free Radic Biol Med       Date:  2017-11-15       Impact factor: 7.376

7.  Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability.

Authors:  Vinod K Mishra; Mayakonda N Palgunachari; David T McPherson; Gattadahalli M Anantharamaiah
Journal:  Biochem Biophys Res Commun       Date:  2012-12-19       Impact factor: 3.575

8.  Cross-linking modifications of HDL apoproteins by oxidized phospholipids: structural characterization, in vivo detection, and functional implications.

Authors:  Detao Gao; Mohammad Z Ashraf; Lifang Zhang; Niladri Kar; Tatiana V Byzova; Eugene A Podrez
Journal:  J Biol Chem       Date:  2020-01-06       Impact factor: 5.157

Review 9.  Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.

Authors:  Jun Chen; Xixi Zhang; Reid Millican; Jennifer Sherwood; Sean Martin; Hanjoong Jo; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Adv Drug Deliv Rev       Date:  2021-01-09       Impact factor: 15.470

10.  Native and oxidised lipoproteins negatively regulate the serum amyloid A-induced NLRP3 inflammasome activation in human macrophages.

Authors:  Katariina Nurmi; Katri Niemi; Ilona Kareinen; Kristiina Silventoinen; Martina B Lorey; Yan Chen; Vesa-Petteri Kouri; Jukka Parantainen; Timo Juutilainen; Katariina Öörni; Petri T Kovanen; Dan Nordström; Sampsa Matikainen; Kari K Eklund
Journal:  Clin Transl Immunology       Date:  2021-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.